Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
International Immunopharmacology|April 30, 2021
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.Hepatology International|May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trialYu Wang, Huifen Wang, Jun Cheng, et al.Medicine|November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitisHong Ma, Minde Zeng, Ying Han, et al.Expert Review of Vaccines|January 21, 2025
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variantsGuiqiang Wang, Kexin Zhao, Xiuli Zhao, et al.Virology Journal|October 30, 2016
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patientsSong Yang, Huichun Xing, Yuming Wang, et al.Gut|June 24, 2025
Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trialJunqi Niu, Yanhang Gao, Guiqiang Wang, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2014
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trialJun Cheng, Yuming Wang, Jinlin Hou, et al.Clinical and Molecular Hepatology|January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.Hepatology International|March 9, 2024
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infectionsTao Chen, Guang Chen, Guiqiang Wang, et al.Journal of Gastroenterology and Hepatology|January 31, 2018
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in ChinaLai Wei, Qing Xie, Jin Lin Hou, et al.Pageof 13